Plante Moran Financial Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Plante Moran Financial Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-380	Closed	–	–	875
2019 Q1	$0	Hold	380	–	–	﹤0.01%	1011
2018 Q4	$0	Hold	380	–	–	﹤0.01%	1012
2018 Q3	$1K	Hold	380	–	–	﹤0.01%	745
2018 Q2	$1K	Hold	380	–	–	﹤0.01%	799
2018 Q1	$1K	Hold	380	–	–	﹤0.01%	944
2017 Q4	$2K	Hold	380	–	–	﹤0.01%	813
2017 Q3	$2K	Hold	380	–	–	﹤0.01%	749
2017 Q2	$1K	Hold	380	–	–	﹤0.01%	823
2017 Q1	$3K	Hold	380	–	–	﹤0.01%	779
2016 Q4	$3K	Hold	380	–	–	﹤0.01%	835
2016 Q3	$4K	Hold	380	–	–	﹤0.01%	768
2016 Q2	$5K	Hold	380	–	–	﹤0.01%	660
2016 Q1	$4K	Hold	380	–	–	﹤0.01%	641
2015 Q4	$9K	Hold	380	–	–	0.01%	607
2015 Q3	$6K	Hold	380	–	–	﹤0.01%	572
2015 Q2	$9K	Buy	+380	New	+$9.37K	0.01%	553

Plante Moran Financial Advisors's OMED Position: Q2 2019 in Review

Plante Moran Financial Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 380 shares.

Plante Moran Financial Advisors first reported a position in OMED in Q2 2015 and held it in 16 quarters. The position peaked at $9K in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Plante Moran Financial Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Plante Moran Financial Advisors sold 380 OncoMed Pharmaceuticals, Inc. shares in Q2 2019.
Plante Moran Financial Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
Plante Moran Financial Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $9K in Q4 2015.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.